Baxter Appoints Jeffrey A. Craig to Its Board
Baxter International Inc. (NYSE:BAX), a global medtech leader, has appointed Jeffrey (Jay) A. Craig to its board of directors. Craig, former executive chair and CEO of Meritor , will serve on Baxter's Audit Committee. His appointment is effective immediately, bringing the total number of directors to 12. Baxter's chair, president and CEO, José (Joe) E. Almeida, expressed excitement about Craig's addition, highlighting his broad-based business leadership and operational expertise as a former CEO, CFO, COO, and public company auditor. This appointment is expected to complement the current board's expertise with Craig's deep financial experience and public company board background.
Baxter International Inc. (NYSE:BAX), un leader globale nel settore della tecnologia medica, ha nominato Jeffrey (Jay) A. Craig nel suo consiglio di amministrazione. Craig, ex presidente esecutivo e CEO di Meritor, farà parte del Comitato di Vigilanza di Baxter. La sua nomina è immediatamente efficace, portando il numero totale di membri del consiglio a 12. José (Joe) E. Almeida, presidente, CEO e chairman di Baxter, ha espresso entusiasmo per l'aggiunta di Craig, evidenziando la sua leadership aziendale e competenza operativa di ampio respiro come ex CEO, CFO, COO e revisore di società pubbliche. Si prevede che questa nomina completi l'expertise attuale del consiglio con la profonda esperienza finanziaria di Craig e il suo background nel consiglio di amministrazione di società pubbliche.
Baxter International Inc. (NYSE:BAX), un líder global en tecnología médica, ha designado a Jeffrey (Jay) A. Craig para su junta directiva. Craig, ex presidente ejecutivo y CEO de Meritor, formará parte del Comité de Auditoría de Baxter. Su nombramiento es efectivo de inmediato, elevando el número total de directores a 12. José (Joe) E. Almeida, presidente, CEO y chairman de Baxter, expresó su entusiasmo por la incorporación de Craig, destacando su liderazgo empresarial integral y experiencia operativa como ex CEO, CFO, COO y auditor de empresas públicas. Se espera que este nombramiento complemente la experiencia actual de la junta con la amplia experiencia financiera de Craig y su historial en juntas de empresas públicas.
Baxter International Inc. (NYSE:BAX), 글로벌 메드테크 리더,가 제프리(Jay) A. 크레이그를 이사회에 임명했습니다. 크레이그는 Meritor의 전 집행 회장 겸 CEO로, Baxter의 감사위원회에서 활동할 예정입니다. 그의 임명은 즉시 발효되며, 이사 수는 총 12명으로 증가합니다. Baxter의 회장, 사장 및 CEO인 José (Joe) E. Almeida는 크레이그의 합류에 대해 흥분을 표명하며, 그의 폭넓은 비즈니스 리더십 및 운영 전문성을 강조했습니다. 이 임명은 크레이그의 깊은 재무 경험과 공공 기업 이사회 배경으로 현재 이사회의 전문성을 보완할 것으로 예상됩니다.
Baxter International Inc. (NYSE:BAX), un leader mondial dans la technologie médicale, a nommé Jeffrey (Jay) A. Craig à son conseil d'administration. Craig, ancien président exécutif et PDG de Meritor, siégera au Comité d'Audit de Baxter. Sa nomination prend effet immédiatement, portant le nombre total de directeurs à 12. José (Joe) E. Almeida, président et PDG de Baxter, a exprimé son enthousiasme pour l'ajout de Craig, soulignant son leadership commercial diversifié et son expertise opérationnelle en tant qu'ancien PDG, CFO, COO et auditeur d'entreprises publiques. Cette nomination devrait compléter l'expertise actuelle du conseil avec l'expérience financière approfondie de Craig et son parcours dans les conseils d'administration d'entreprises publiques.
Baxter International Inc. (NYSE:BAX), ein globaler Medizintechnikführer, hat Jeffrey (Jay) A. Craig in seinen Vorstand berufen. Craig, ehemaliger Executive Chairman und CEO von Meritor, wird im Audit-Ausschuss von Baxter tätig sein. Seine Ernennung tritt sofort in Kraft und erhöht die Gesamtzahl der Direktoren auf 12. José (Joe) E. Almeida, Vorsitzender, Präsident und CEO von Baxter, äußerte sich begeistert über Craigs Hinzukommen und hob seine breite Führungskompetenz und operative Expertise als ehemaliger CEO, CFO, COO und Wirtschaftsprüfer von öffentlichen Unternehmen hervor. Diese Ernennung soll die bestehende Expertise des Vorstands mit Craigs umfassender finanzieller Erfahrung und seinem Hintergrund in öffentlichen Unternehmensvorständen ergänzen.
- Addition of a highly experienced executive to the board
- Strengthening of the Audit Committee with Craig's financial expertise
- Expansion of board diversity and skill set
- None.
Addition of Mr. Craig complements current board expertise with deep financial, broad operational and public company board experience
“We are excited to welcome Jay to Baxter’s board,” said José (Joe) E. Almeida, chair, president and CEO. “As a former CEO, CFO, COO and public company auditor, Jay’s broad-based business leadership and operational expertise will be a tremendous complement to our current board membership.”
About Jay Craig
Mr. Craig most recently served as executive chair and CEO of Meritor Corporation, a global supplier of drivetrain, mobility, braking and aftermarket solutions for commercial vehicles, where he had also previously held roles of increasing leadership including controller, chief financial officer, and president and chief operating officer. Prior to joining Meritor, he was president, GMAC Commercial, a
About Baxter
Every day, millions of patients, caregivers and healthcare providers rely on Baxter’s leading portfolio of diagnostic, critical care, kidney care, nutrition, hospital and surgical products used across patient homes, hospitals, physician offices and other sites of care. For more than 90 years, we’ve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers who make it happen. With products, digital health solutions and therapies available in more than 100 countries, Baxter’s employees worldwide are now building upon the company’s rich heritage of medical breakthroughs to advance the next generation of transformative healthcare innovations. To learn more, visit www.baxter.com and follow us on X, LinkedIn and Facebook.
Baxter is a registered trademark of Baxter International Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240906567171/en/
Media Contact
Stacey Eisen, (224) 948-5353
media@baxter.com
Investor Contact
Clare Trachtman, (224) 948-3020
Source: Baxter International Inc.
FAQ
Who is the new board member appointed by Baxter International (BAX)?
What committee will Jeffrey Craig serve on at Baxter (BAX)?
How many directors are now on Baxter's (BAX) board after this appointment?
What experience does Jeffrey Craig bring to Baxter's (BAX) board?
